W09--Gastrointestinal Involvement in CF | Room: Terrace Suite (Level 4)
W09.3- Changes in fecal microbiome and relationships with gut inflammation and abdominal symptoms over 6 months of treatment with Elexacaftor/Tezacaftor/Ivacaftor in people with CF – results from RECOVER